Page last updated: 2024-08-22

magnesium sulfate and Sensation Disorders

magnesium sulfate has been researched along with Sensation Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atkins, CD	1
Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB	1

Trials

2 trial(s) available for magnesium sulfate and Sensation Disorders

Article	Year
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Feb-01, Volume: 29, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome	2011
The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:3 Topics: Anticonvulsants; Disability Evaluation; Disabled Children; Female; Humans; Infant; Magnesium Sulfate; Nervous System Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Sensation Disorders	2007

Article

Year

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Feb-01, Volume: 29, Issue:4

Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome

2011

The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months.

BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:3

Topics: Anticonvulsants; Disability Evaluation; Disabled Children; Female; Humans; Infant; Magnesium Sulfate; Nervous System Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Sensation Disorders

2007

Other Studies

1 other study(ies) available for magnesium sulfate and Sensation Disorders

Article	Year
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-10, Volume: 32, Issue:29 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders	2014

Article

Year

Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-10, Volume: 32, Issue:29

Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders

2014